Affimed Receives FDA Fast Track Designation for AFM13 in Combination with AlloNK® for the Treatment of Patients with Relapsed or Refractory Hodgkin Lymphoma
September 12, 2023
September 12, 2023
September 7, 2023
August 22, 2023
August 10, 2023
August 3, 2023
July 31, 2023
June 22, 2023
June 9, 2023
June 3, 2023
June 3, 2023